This inventor holds 1 USPTO granted patent. Top assignee: Iogenetics, LLC. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Thomas Hope: Innovator in Transgenic Animal Research
Introduction
Thomas Hope is a notable inventor based in Oak Brook, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of transgenic animals. His work focuses on innovative methods for controlling complex retroviral infections.
Latest Patents
Thomas Hope holds a patent for "Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins." This invention relates to non-vaccinal and non-pharmacologic compositions and methods for managing retroviral infections. The patent specifically provides transgenic animals that express a transdominant negative Rex gene product, which inhibits retroviral replication.
Career Highlights
Throughout his career, Thomas has been associated with Iogenetics, LLC, where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding of retroviral mechanisms and potential treatments.
Collaborations
Thomas has collaborated with notable colleagues, including Robert D Bremel and Jane Homan. These partnerships have contributed to the success of his research initiatives and the advancement of innovative solutions in biotechnology.
Conclusion
Thomas Hope's contributions to the field of transgenic research highlight his commitment to addressing complex medical challenges. His innovative patent and collaborative efforts underscore the importance of scientific advancement in combating retroviral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile